FSTL1 and lung adenocarcinoma: Considering that type II pneumocytes are generally regarded as the origin of lung adenocarcinoma33, 34, it is reasonable that FSTL1-BMP4-Smad pathway dysregulation could result in strong prognostic impacts on lung adenocarcinoma patients.